Kim Fookes is only about a month into her role as global head of diversity and inclusion in clinical trials at Novartis AG, but her work to help improve clinical trial diversity – especially in the US – predates that by several months, and the company has been making efforts in that regard for multiple years. Now, Novartis is looking to take some of the lessons it has learned in the US abroad as well.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?